Lv1
36 积分 2024-03-27 加入
MEK inhibitor and anti-EGFR antibody overcome sotorasib resistance signals and enhance its antitumor effect in colorectal cancer cells
28天前
已完结
RASH3D19 mediates RAS activation through a positive feedback loop in KRAS-mutant cancer
29天前
已完结
Bispecific T-cell Engager (CD3 × EGFR)-Based Triplet Therapy Unlocks CD40/CD40L Crosstalk to Revert Immunosuppression in Third-Generation EGFR-Tyrosine Kinase Inhibitor–Refractory NSCLC
1个月前
已完结
RTN4IP1 Contributes to ESCC via Regulation of Amino Acid Transporters
1个月前
已完结
Targeting CLK1/SRSF7 axis-dependent alternative splicing sensitizes pancreatic ductal adenocarcinoma to chemotherapy and immunotherapy
1个月前
已完结
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
1个月前
已完结
MTAP Loss Is Frequent in Oncogene-Driven NSCLC and May Confer Sensitivity to Combined PRMT5 Inhibitors and Targeted Therapies
1个月前
已完结
Datopotamab deruxtecan: rational strategies, novel advancements, challenges, and future perspectives
2个月前
已完结
Sacituzumab tirumotecan improves OS in mTNBC
2个月前
已完结
Multivalent linkers: A growing trend in antibody–drug conjugate development
2个月前
已完结
皖公网安备34019202002308
